Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13519472 | 0.85 | FAAH (0.36) | FAAHMGLLPOLBSMN1; SMN2CYP3A4 | |
| SCHEMBL13519479 | 0.78 | FAAH (0.35) | FAAHMGLLCYP3A4 | |
| SCHEMBL7239641 | 0.73 | FAAH (0.50) | FAAHMGLLPOLBCYP2C9CYP3A4 | |
| SCHEMBL1162413 | 0.72 | HSPA5 (0.36) | POLBSMN1; SMN2CYP2C9 | |
| SCHEMBL24000883 | 0.70 | RAB9A (0.53) | SMN1; SMN2NAMPTCYP3A4 | |
| SCHEMBL13519357 | 0.70 | FAAH (0.33) | FAAHMGLL | |
| SCHEMBL1162810 | 0.69 | CYP17A1 (0.35) | CYP3A4 | |
| SCHEMBL13519395 | 0.69 | MAPT (0.30) | — | |
| SCHEMBL13519388 | 0.68 | FDPS (0.36) | — | |
| SCHEMBL13519420 | 0.68 | ACP1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230256413-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION (US) | 2023-08-17 | — | — | US | disclosed |
| EP-4129466-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2023-02-08 | — | — | EP | disclosed |
| US-20210220753-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-22 | — | — | US | disclosed |
| US-10974167-B2 | High purity chromatographic materials comprising an ionizable modifier | WATERS TECHNOLOGIES CORPORATION (US) | 2021-04-13 | — | — | US | disclosed |
| US-20190126241-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION | 2019-05-02 | — | — | US | disclosed |
| US-20190091606-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2019-03-28 | — | — | US | disclosed |
| US-10159911-B2 | High purity chromatographic materials comprising an ionizable modifier | WATERS TECHNOLOGIES CORPORATION (US) | 2018-12-25 | — | — | US | disclosed |
| US-10150098-B2 | High purity chromatographic materials comprising an ionizable modifier | WATERS TECHNOLOGIES CORPORATION (US) | 2018-12-11 | — | — | US | disclosed |
| US-20130319086-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2013-12-05 | — | — | US | disclosed |
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | SPECC1L, SAMM50, RAB5IF | FAAH 2130/4885MGLL 885/4885POLB 4352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.